DiaGenic ASA Product Pipeline Analysis

SUMMARY

DiaGenic ASA Product Pipeline Analysis

Summary

This report is an insightful source for data, analysis and strategic insights into a DiaGenic ASA's pipeline and investigational products. The report also provides details on clinical trials covering trial phase, description, investigator information, primary and secondary end-points and trial results for products in development.

Scope

• Details of development stage by sector and equipment type.
• Pipeline products grouped by therapy area, development stage and trial phase.
• Detailed information on clinical trials covering trial phase, description, investigator .nformation, primary and secondary end-points and trial results.
• Trial updates, trial start and end dates, patient numbers and the trials primary outcome measures, secondary outcome measures.
• Product updates covering estimated approval dates and estimated launch dates.
• Descriptions of novel technologies relating to pipeline products of the company.
• Patents and patent applications covered for the product.
• News updates on key events relating to the product and its development.

Reasons to buy

• A single source to fulfill competitor information relating to products in development.
• Identify pipeline products that are potential competitor to your product lines.
Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline.
• Access clinical trial information to map trial results and plan targeted marketing activities.
• Take corrective measures on your own development programs and R&D initiatives based on regulatory events of competitor product pipelines.
• Identification of potential investment opportunities.
• Build up knowledge base for potential distribution and marketing partners.
• Helps avoid patent infringement.
• Timelines from concept to market lets you keep track of market potential build for a new product.
Assess a company's future growth by determining its pipeline depth, for probable acquisition opportunities.

TABLE OF CONTENTS

1 Table of Contents 3
1.1 List of Tables 6
1.2 List of Figures 7
2 Company Snapshot 8
2.1 Key Information 8
2.2 Company Overview 8
2.3 Financial Performance 8
2.4 Industry Outlook -- In Vitro Diagnostics 8
3 Business Description 9
3.1 Business Overview 9
3.2 Major Products and Services 9
3.2.1 Overview 9
4 Competitors 10
5 Key Employees 11
6 Key Employee Biographies 12
7 Company Statement 13
8 Locations And Subsidiaries 14
8.1 Head Office 14
9 Recent Developments 15
9.1 Financial Announcements 15
9.1.1 Apr 29, 2008: DiaGenic Reports Q1 2008 Results 15
9.1.2 Feb 14, 2008: DiaGenic Reports Q4 2007 Results 16
9.1.3 Oct 25, 2007: DiaGenic Reports Q3 2007 Results 17
9.1.4 Aug 15, 2007: DiaGenic Reports Q2 2007 Results 17
9.1.5 Apr 25, 2007: DiaGenic Reports Q1 2007 Results 18
9.1.6 Feb 15, 2007: DiaGenic Reports Q4 2006 Results 18
9.2 Product News 19
9.2.1 May 23, 2008: DiaGenic Appoints SRL RANBAXY Pathology Laboratories For Marketing DiaGenic's Early Breast Cancer Test In India 19
9.2.2 Feb 04, 2008: Diagenic Announces Preliminary Results From A Multicenter Breast Cancer Study In India 19
9.3 Clinical Trials 20
9.3.1 Feb 04, 2008: Diagenic Announces Preliminary Results From A Multicenter Breast Cancer Study In India 20
10 DiaGenic ASA Pipeline Products 21
10.1 DiaGenic ASA Product Pipeline Analysis 21
10.1.1 DiaGenic ASA Pipeline Products By Equipment Type 21
10.1.2 DiaGenic ASA Pipeline Products By Development Stage 22
10.1.3 DiaGenic ASA Pipeline Products By Therapy Area 22
10.1.4 DiaGenic ASA Pipeline Products By Clinical Trials 23
10.1.5 DiaGenic ASA Pipeline Products By News Summary 23
10.2 Signature Test 23
10.2.1 Product Description 23
10.2.2 Product Status 23
10.3 DiaGenic breast cancer blood test 24
10.3.1 Product Description 24
10.3.2 Product Status 24
10.3.3 Clinical Trials 24
10.3.4 Product Milestone 25
10.4 Blood test for Parkinson's disease 25
10.4.1 Product Description 25
10.4.2 Product Status 26
11 Appendix 27
11.1 Methodology 27
11.1.1 Coverage 27
11.1.2 Secondary Research 28
11.1.3 Primary Research 28
11.1.4 Expert Panel Validation 29
11.2 Contact Us 29
11.3 About Global Markets Direct 29
11.4 Disclaimer 29

1.1 List of Tables
Table 1: DiaGenic ASA,Key Facts 8
Table 2: DiaGenic ASA, Key Employees, 11
Table 3: DiaGenic ASA Pipeline Products by Equipment Type 21
Table 4: DiaGenic ASA Pipeline Products By Development Stage 22
Table 5: DiaGenic ASA Pipeline Products By Therapy Area 22
Table 6: DiaGenic ASA Pipeline Products By Clinical Trials 23
Table 7: DiaGenic ASA Pipeline Products By News Summaries 23

1.2 List of Figures
Figure 1: DiaGenic ASA Pipeline Products By Development Stage 22
Figure 2: Global Markets Direct Methodology 27